Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Radiopharm Theranostics said its Phase 1 imaging trial of RAD301 in pancreatic ductal adenocarcinoma showed positive safety and favourable biodistribution in all dosed subjects, with significant tumour uptake in all evaluable patients.
Radiopharm Theranostics said Phase 1 imaging trial data for RAD301 in pancreatic ductal adenocarcinoma patients was positive.